XENE

Biotechnology Uncategorized XENE

Xenon Pharmaceuticals prices upsized $650M public offering at $57/share

Mar 11, 2026

Biotechnology Uncategorized XENE

Xenon Pharmaceuticals announces proposed $500M public share offering

Mar 9, 2026

Biotechnology MITT Uncategorized XENE

Xenon announces positive topline data from phase 3 X-TOLE2 study of azetukalner

Mar 9, 2026

Biotechnology Edmund Ingham Uncategorized XENE

Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked

Mar 9, 2026